Type 2 Diabetes clinical trials
Showing 251–300 of 391 active trials. Describe your situation to see which ones you may be eligible for.
- Michigan Men's Diabetes Project III(MenDIII): Mind and Motion
- Implementing an Effective Diabetes Intervention Among Low-Income Immigrants
- Salud Diabetes: A Pilot Study Comparing Lifestyle Interventions and Real-Time Continuous Glucose Monitoring
- Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
- Extracellular Vesicles, Insulin Action, and Exercise
- Enhancing Digitally Delivered Diabetes Education With Real-Time CGM
- The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
- Diabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-management
- THC Effects on Glucose in Type 2 Diabetes
- Quantifying Hepatic Mitochondrial Fluxes in Humans
- Remote Physical Activity Programming to Improve Outcomes in Cancer Survivors With and Without Type 2 Diabetes
- Exercise and Protein Efficiency in T2D
- Addressing Diabetes by Elevating Access to Nutrition
- Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
- Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
- Groceries Plus Multi-Component Lifestyle Intervention for Adults With Hypertension and Type 2 Diabetes
- Joint Patient and Caregiver Intervention for Older African Americans With Type 2 Diabetes
- Culturally Tailored Program for Food-Insecure Adults: SPICE-D
- OASIS: Peer Support for T2DM in Appalachia (Peer Participant)
- Family Model DSME in FBOs in the RMI
- Diabetes Body Project 2
- Effects of Ketone Ester Consumption on Exercise Tolerance and Cardiac Function
- Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
- The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults
- Mechanisms of Fatigability With Diabetes
- Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access
- Advanced Fibrosis Detection for MASLD in Primary Care
- Diazoxide Suppression Test P&F Study
- Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
- Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
- Graded Insulin Suppression Test P&F
- Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
- Food and Fitness With Medicine (FFWM)
- Using Virtual Reality to Improve Medical Training
- Implementing Food Referrals for Equity and Sustained Health
- Study of Fetal Health Outcomes: Working With a Missouri E-telehealth Platform (The SHOW-ME Study)
- PLAY2CONTROL Study
- A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients
- A1Cantus vs. Placebo
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
- Combined Circulatory and Dietary Interventions for Neuropathy
- Real-time Engagement for Learning to Effectively Control Type 2 Diabetes
- Injection Ports vs Single-Use Needles for Insulin in Pregnancy: Effects on Adherence and Satisfaction
- Group Emotion-Focused Behavioral Intervention for Diabetes Distress/A1c in T2D.
- A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus.
- CGM After Discharge From Hospital
- Glucose Control in Type 2 Diabetes in Pregnancy
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.